# Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer

> **NCT00004103** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health**

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** floxuridine
- **DRUG:** irinotecan hydrochloride
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy

## Key facts

- **NCT ID:** NCT00004103
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-07
- **Primary completion:** 2007-03
- **Final completion:** 2009-06
- **Target enrollment:** — (—)
- **Last updated:** 2011-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004103, "Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00004103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*